3rd Quarter - Report
FEROX STRATEGIES for FRESENIUS KABI USA LLC
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General healthcare issues related to biosimilar industries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| DEBRA DIXON | — |
| ZACHARY BENJAMIN FRIEND | — |
| MICHAEL TAGGART | — |
| MARK WILLIAMS | — |
Pharmacy PHA
General patent issues related to biosimilar industries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| DEBRA DIXON | — |
| ZACHARY BENJAMIN FRIEND | — |
| MICHAEL TAGGART | — |
| MARK WILLIAMS | — |
Trade (domestic/foreign) TRD
General issues related to trade.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| DEBRA DIXON | — |
| ZACHARY BENJAMIN FRIEND | — |
| MICHAEL TAGGART | — |
| MARK WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.